Hogan Lovells Snags Drug Regulatory Pro From Sidley Austin

Law360, New York (February 20, 2013, 3:45 PM EST) -- Hogan Lovells has bolstered its government regulatory practice by luring away a Sidley Austin LLP counsel with more than a decade of experience representing pharmaceutical, biotechnology and medical device companies, the firm announced Tuesday.

Gary L. Veron has spent many years working on regulatory and intellectual property matters in food and drug law, helping clients deal with numerous U.S. Food and Drug Administration regulatory and enforcement issues. He has particular expertise with the Hatch-Waxman Act issues, including market exclusivity periods and patent term extensions.

Veron, who began...
To view the full article, register now.